More Anal Cancer Drugs Are Coming Despite Incyte Stumble

September 9

This summer, Incyte Corp. hit a roadblock in the company’s quest to have its drug retifanlimab become the first FDA-approved treatment of its kind for patients with the most common type of anal cancer.

Retifanlimab is an immune checkpoint inhibitor (also known as immunotherapy) that aims to treat adult patients with locally advanced or metastatic squamous cell carcinoma of the anal canal (SCAC) whose disease has progressed after receiving platinum-based chemotherapy or who were intolerant of that type of chemotherapy. Currently, there are no approved treatment options available to patients who meet these criteria, according to Incyte.

0 Comments

Radar on Drug Benefits

Leslie Small

Leslie has been reporting and editing in various journalism roles for nearly a decade. Most recently, she was the senior editor of FierceHealthPayer, an e-newsletter covering the health insurance industry. A graduate of Penn State University, she previously served in editing roles at newspapers in Pennsylvania, Virginia and Colorado.

Experts Mull How Life Sciences Firms Can Prep for ‘New Normal’ September 9, 2021

PhRMA Takes Aim at Medicare Price Negotiation as HHS Digs In September 9, 2021

May 25

Commercial Insurance Restrictions Complicate Biosimilar Adoption

May 25

‘Shell Game’ or Rebate Maximizers? FTC Probe Reignites Debate Over GPOs

May 25

As Weight Loss Drugs’ Star Rises, Plan Sponsors, Researchers Worry About Costs

Meet Our Reporters

Lauren Flynn Kelly Executive Editor, AIS Health, and Managing Editor, Radar on Medicare Advantage
View Lauren Flynn Kelly's Profile
Angela Maas Managing Editor, Radar on Specialty Pharmacy and Spotlight on Market Access
View Angela Maas's Profile
Leslie Small Managing Editor, Health Plan Weekly and Radar on Drug Benefits
View Leslie Small's Profile
Peter Johnson Reporter, Health Plan Weekly and Radar on Drug Benefits
View Peter Johnson's Profile
Tim Casey Reporter, Health Plan Weekly and Radar on Drug Benefits
View Tim Casey's Profile
Carina Belles Reporter, Radar on Medicare Advantage and Spotlight on Market Access
View Carina Belles's Profile
Jinghong Chen Reporter, Health Plan Weekly and Radar on Drug Benefits
View Jinghong Chen's Profile

Cookie	Duration	Description
__hssc	30 minutes	HubSpot sets this cookie to keep track of sessions and to determine if HubSpot should increment the session number and timestamps in the __hstc cookie.
__hssrc	session	This cookie is set by Hubspot whenever it changes the session cookie. The __hssrc cookie set to 1 indicates that the user has restarted the browser, and if the cookie does not exist, it is assumed to be a new session.
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie records the user consent for the cookies in the "Advertisement" category.
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent	1 year	CookieYes sets this cookie to record the default button state of the corresponding category and the status of CCPA. It works only in coordination with the primary cookie.
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Cookie	Duration	Description
__cf_bm	30 minutes	Cloudflare set the cookie to support Cloudflare Bot Management.
__sharethis_cookie_test__	session	ShareThis sets this cookie to track which pages are being shared and by whom.
_vis_opt_s	3 months 8 days	Visual Website Optimizer sets this cookie to detect if there are new to or returning to a particular test.
_vis_opt_test_cookie	session	Visual Website Optimizer creates this cookie to determine whether or not cookies are enabled on the user's browser.
drift_aid	1 year 1 month 4 days	Drift sets this cookie as a session identifier token. It is used to tie the visitor on your website to a current website session within the Drift system. This enables session-specific features, such as popping up a message only once during a 30 minute session to prevent a disruptive experience.
drift_campaign_refresh	30 minutes	Drift sets this cookie as a unique ID for the specific user. This allows the website to target the user with relevant offers through its chat functionality.
driftt_aid	1 year 1 month 4 days	Drift sets this cookie as an anonymous identifier token. As people come onto the site, they will get this cookie.
li_gc	5 months 27 days	Linkedin set this cookie for storing visitor's consent regarding using cookies for non-essential purposes.
lidc	1 day	LinkedIn sets the lidc cookie to facilitate data center selection.
UserMatchHistory	1 month	LinkedIn sets this cookie for LinkedIn Ads ID syncing.

Cookie	Duration	Description
_vwo_ds	3 months	This cookie stores persistent user-level data for VWO Insights.
_vwo_sn	30 minutes	This cookie stores session-level information.
_vwo_uuid	1 year 1 month 4 days	Visual Website Optimizer sets this cookie to generate a unique id for every visitor and for its report segmentation feature. The cookie also allows to view data in a more refined manner.

Cookie	Duration	Description
__hstc	5 months 27 days	Hubspot set this main cookie for tracking visitors. It contains the domain, initial timestamp (first visit), last timestamp (last visit), current timestamp (this visit), and session number (increments for each subsequent session).
_fbp	3 months	Facebook sets this cookie to display advertisements when either on Facebook or on a digital platform powered by Facebook advertising after visiting the website.
_ga	1 year 1 month 4 days	Google Analytics sets this cookie to calculate visitor, session and campaign data and track site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognise unique visitors.
_ga_*	1 year 1 month 4 days	Google Analytics sets this cookie to store and count page views.
_gat_gtag_UA_*	1 minute	Google Analytics sets this cookie to store a unique user ID.
_gcl_au	3 months	Google Tag Manager sets the cookie to experiment advertisement efficiency of websites using their services.
_gid	1 day	Google Analytics sets this cookie to store information on how visitors use a website while also creating an analytics report of the website's performance. Some of the collected data includes the number of visitors, their source, and the pages they visit anonymously.
_vwo_uuid_v2	1 year	This cookie is set by Visual Website Optimiser and calculates unique traffic on a website.
ajs_anonymous_id	1 year	This cookie is set by Segment to count the number of people who visit a certain site by tracking if they have visited before.
AnalyticsSyncHistory	1 month	Linkedin set this cookie to store information about the time a sync took place with the lms_analytics cookie.
CONSENT	2 years	YouTube sets this cookie via embedded YouTube videos and registers anonymous statistical data.
fs_uid	1 year	This cookie is set by the provider Fullstory. This cookie is used for session tracking.
hubspotutk	5 months 27 days	HubSpot sets this cookie to keep track of the visitors to the website. This cookie is passed to HubSpot on form submission and used when deduplicating contacts.
ln_or	1 day	Linkedin sets this cookie to registers statistical data on users' behaviour on the website for internal analytics.
vuid	1 year 1 month 4 days	Vimeo installs this cookie to collect tracking information by setting a unique ID to embed videos on the website.

Cookie	Duration	Description
bcookie	1 year	LinkedIn sets this cookie from LinkedIn share buttons and ad tags to recognize browser IDs.
bscookie	1 year	LinkedIn sets this cookie to store performed actions on the website.
fr	3 months	Facebook sets this cookie to show relevant advertisements by tracking user behaviour across the web, on sites with Facebook pixel or Facebook social plugin.
IDE	1 year 24 days	Google DoubleClick IDE cookies store information about how the user uses the website to present them with relevant ads according to the user profile.
muc_ads	1 year 1 month 4 days	Twitter sets this cookie to collect user behaviour and interaction data to optimize the website.
personalization_id	1 year 1 month 4 days	Twitter sets this cookie to integrate and share features for social media and also store information about how the user uses the website, for tracking and targeting.
test_cookie	15 minutes	doubleclick.net sets this cookie to determine if the user's browser supports cookies.
VISITOR_INFO1_LIVE	5 months 27 days	YouTube sets this cookie to measure bandwidth, determining whether the user gets the new or old player interface.
YSC	session	Youtube sets this cookie to track the views of embedded videos on Youtube pages.

More Anal Cancer Drugs Are Coming Despite Incyte Stumble

Leslie Small

Related Posts

Commercial Insurance Restrictions Complicate Biosimilar Adoption

‘Shell Game’ or Rebate Maximizers? FTC Probe Reignites Debate Over GPOs

As Weight Loss Drugs’ Star Rises, Plan Sponsors, Researchers Worry About Costs

The Latest

Premium Categories

Meet Our Reporters

Lauren Flynn Kelly Executive Editor, AIS Health, and Managing Editor, Radar on Medicare Advantage

Angela Maas Managing Editor, Radar on Specialty Pharmacy and Spotlight on Market Access

Leslie Small Managing Editor, Health Plan Weekly and Radar on Drug Benefits

Peter Johnson Reporter, Health Plan Weekly and Radar on Drug Benefits

Tim Casey Reporter, Health Plan Weekly and Radar on Drug Benefits

Carina Belles Reporter, Radar on Medicare Advantage and Spotlight on Market Access

Jinghong Chen Reporter, Health Plan Weekly and Radar on Drug Benefits

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND